Equity transactions	12 Months Ended
Jun. 30, 2020
Equity [Abstract]
Equity transactions	26. Equity transactions The Company is authorized to issue 10,000,000,000 shares of $.001 par value common stock and 10,000,000 shares of $.001 par value preferred stock. On April 22, 2020, the Company filed an amendment to increased the total authorized shares to 10,010,000,000 – 10,000,000,000 shall be designated common stock, par $0.001 per share and 10,000,000 shares shall be designated as preferred stock, par value $0.001 per share. During the year ended June 30, 2018, the Company issued 1,171,429 shares of common stock for cash in total amount of $82,000. During the year ended June 30, 2018, the Company issued 4,736,842 shares of common stock for services in total amount of $180,000. During the year ended June 30, 2018, the Company issued 13,492,560 shares of common stock to settle the old debt in total amount of $306,810. During the year ended June 30, 2019, the Company issued 8,658,685 shares of common stock to settle the old debt in total amount of $665,918. During the year ended June 30, 2019, the Company issued 121,332,262 shares of common stock to convert the convertible notes in total amount of $2,783,237. During the year ended June 30, 2019, the Company issued 14,842,857 shares of common stock for cash in total amount of $390,000. During the year ended June 30, 2019, the Company issued 96,639,563 shares of common stock for services in total amount of $6,660,643. During the year ended June 30, 2019, the Company (buyer) signed a letter of intent (LOI) regarding a potential acquisition of all the outstanding capital stock, assets and assumption of liabilities of a company (seller). The Company issued 10,000,000 shares of common stock as the stock compensations upon the signing of the LOI in total amount of $1,175,000. The share is non-refundable and vested immediately, but was issued on a restricted basis with a restrictive legend and will be subject to normal restrictions imposed by the financial industry and governmental agencies. During the year ended June 30, 2019, the Company issued 200,000,000 shares of common stock as deposit for acquisition of BZRTH with a total value of $18,000,000. See Note 4 for details. During the year ended June 30, 2019, the Company issued 2,000,000 shares of Series A preferred stock to multiple investors for EB-5 project to be issued in prior years. As of June 30, 2019, the Company had 697,608,570 shares of its common stock issued and outstanding and 2,000,000 shares of its Series A preferred stock issued and outstanding. During the year ended June 30, 2020, the Company issued 138,461,538 shares of common stock for cash in total amount of $690,287. During the year ended June 30, 2020, the Company issued 1,077,643,486 shares of common stock to convert the convertible notes in total amount of $1,959,527. During the year ended June 30, 2020, the Company issued 28,381,818 shares of common stock for warrant exercise in total fair value of $690,287. During the year ended June 30, 2020, the Company issued 1,500,000 shares of common stock for service in total fair value of $81,200. During the year ended June 30, 2020, the Company issued 19,181,818 shares of common stock to settle the old debt in total fair value of $290,455. During the year ended June 30, 2020, the Company issued 249,373,817 shares of common stock for acquisition of BZRTH in total fair value of $3,566,046. The shares were cancelled pursuant to the rescission on January 15, 2020. During the year ended June 30, 2020, the Company issued 750,001 shares of preferred stock for acquisition of BZRTH in total fair value of $10,725,014. The shares of preferred stock were cancelled pursuant to the rescission on January 15, 2020. During the year ended June 30, 2020, the Company issued 415,000 shares of series B preferred stock for award to employee bonus in total fair value of $5,934,500. During the year ended June 30, 2020, the Company issued 1,126,500 shares of series B preferred stock for award to officer’s compensation in total fair value of $2,928,900. On April 17, 2020, the Company entered into a Series B Waiver Agreement (the “Waiver Agreement”) with its chief executive officer and corporate chairman of its board of directors, Jimmy Chan (“Chan”) relating to Chan’s ownership of One Million Five Hundred Thousand (1,500,000) of Series B Convertible Preferred Stock. Under the terms of the Waiver Agreement, Chan waives his rights (a) to the conversion rights granted to him in the Series B Convertible Preferred Stock and (b) the rights to proceeds in the event of any liquidation, dissolution or winding up as may be provided in the Certificate of Incorporation pertaining to said Series B Preferred Stock, if any. In the event that there is a merger or consolidation (other than one in which stockholder of the Company own a majority by voting power of the outstanding shares of the surviving or acquiring corporation) or a sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of the Company, this event will be treated as a liquidation event. The Series B Convertible Preferred Stock continues to vote or have the right to vote, together with the Common Stock as if it were on an as-converted basis, and not as a separate class, subject to any adjustments for stock dividends, splits, combinations and similar events. As of June 30, 2020, the Company had 1,763,277,230 shares of its common stock issued and outstanding. As of June 30, 2020, the Company had 3,541,500 shares of its Series B preferred stock issued and outstanding.

Equity transactions

12 Months Ended

Jun. 30, 2020

26. Equity transactions

The Company is authorized to issue 10,000,000,000 shares of $.001 par value common stock and 10,000,000 shares of $.001 par value preferred stock. On April 22, 2020, the Company filed an amendment to increased the total authorized shares to 10,010,000,000 – 10,000,000,000 shall be designated common stock, par $0.001 per share and 10,000,000 shares shall be designated as preferred stock, par value $0.001 per share.

During the year ended June 30, 2018, the Company issued 1,171,429 shares of common stock for cash in total amount of $82,000.

During the year ended June 30, 2018, the Company issued 4,736,842 shares of common stock for services in total amount of $180,000.

During the year ended June 30, 2018, the Company issued 13,492,560 shares of common stock to settle the old debt in total amount of $306,810.

During the year ended June 30, 2019, the Company issued 8,658,685 shares of common stock to settle the old debt in total amount of $665,918.

During the year ended June 30, 2019, the Company issued 121,332,262 shares of common stock to convert the convertible notes in total amount of $2,783,237.

During the year ended June 30, 2019, the Company issued 14,842,857 shares of common stock for cash in total amount of $390,000.

During the year ended June 30, 2019, the Company issued 96,639,563 shares of common stock for services in total amount of $6,660,643.

During the year ended June 30, 2019, the Company (buyer) signed a letter of intent (LOI) regarding a potential acquisition of all the outstanding capital stock, assets and assumption of liabilities of a company (seller). The Company issued 10,000,000 shares of common stock as the stock compensations upon the signing of the LOI in total amount of $1,175,000. The share is non-refundable and vested immediately, but was issued on a restricted basis with a restrictive legend and will be subject to normal restrictions imposed by the financial industry and governmental agencies.

During the year ended June 30, 2019, the Company issued 200,000,000 shares of common stock as deposit for acquisition of BZRTH with a total value of $18,000,000. See Note 4 for details.

During the year ended June 30, 2019, the Company issued 2,000,000 shares of Series A preferred stock to multiple investors for EB-5 project to be issued in prior years.

As of June 30, 2019, the Company had 697,608,570 shares of its common stock issued and outstanding and 2,000,000 shares of its Series A preferred stock issued and outstanding.

During the year ended June 30, 2020, the Company issued 138,461,538 shares of common stock for cash in total amount of $690,287.

During the year ended June 30, 2020, the Company issued 1,077,643,486 shares of common stock to convert the convertible notes in total amount of $1,959,527.

During the year ended June 30, 2020, the Company issued 28,381,818 shares of common stock for warrant exercise in total fair value of $690,287.

During the year ended June 30, 2020, the Company issued 1,500,000 shares of common stock for service in total fair value of $81,200.

During the year ended June 30, 2020, the Company issued 19,181,818 shares of common stock to settle the old debt in total fair value of $290,455.

During the year ended June 30, 2020, the Company issued 249,373,817 shares of common stock for acquisition of BZRTH in total fair value of $3,566,046. The shares were cancelled pursuant to the rescission on January 15, 2020.

During the year ended June 30, 2020, the Company issued 750,001 shares of preferred stock for acquisition of BZRTH in total fair value of $10,725,014. The shares of preferred stock were cancelled pursuant to the rescission on January 15, 2020.

During the year ended June 30, 2020, the Company issued 415,000 shares of series B preferred stock for award to employee bonus in total fair value of $5,934,500.

During the year ended June 30, 2020, the Company issued 1,126,500 shares of series B preferred stock for award to officer’s compensation in total fair value of $2,928,900.

On April 17, 2020, the Company entered into a Series B Waiver Agreement (the “Waiver Agreement”) with its chief executive officer and corporate chairman of its board of directors, Jimmy Chan (“Chan”) relating to Chan’s ownership of One Million Five Hundred Thousand (1,500,000) of Series B Convertible Preferred Stock. Under the terms of the Waiver Agreement, Chan waives his rights (a) to the conversion rights granted to him in the Series B Convertible Preferred Stock and (b) the rights to proceeds in the event of any liquidation, dissolution or winding up as may be provided in the Certificate of Incorporation pertaining to said Series B Preferred Stock, if any. In the event that there is a merger or consolidation (other than one in which stockholder of the Company own a majority by voting power of the outstanding shares of the surviving or acquiring corporation) or a sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of the Company, this event will be treated as a liquidation event. The Series B Convertible Preferred Stock continues to vote or have the right to vote, together with the Common Stock as if it were on an as-converted basis, and not as a separate class, subject to any adjustments for stock dividends, splits, combinations and similar events.

As of June 30, 2020, the Company had 1,763,277,230 shares of its common stock issued and outstanding.

As of June 30, 2020, the Company had 3,541,500 shares of its Series B preferred stock issued and outstanding.